P47811 (MK14_MOUSE) Mus musculus (Mouse)

Mitogen-activated protein kinase 14 UniProtKBInterProSTRINGInteractive Modelling

360 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 3 identical sequences: Peromyscus maniculatus bairdii: A0A6I9LHS5; Mus caroli: A0A6P5RF57; Cricetulus griseus: A0A8C2MW48

Available Structures

121 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound… Heteromer
Q8CF89;
3-354
SB4;SO4;EDO;
Assess
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) Heteromer
Q8CF89;
3-353
SB4;TLA;EDO;
Assess
Structure of MAP kinase in complex with a docking peptide Heteromer
Q15750;
4-354
Assess
CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A Heteromer
Q02078;
5-354
Assess
CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B Heteromer
O09110;
4-353
Assess
Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) Heteromer
Q8CF89;
5-353
SB4;
Assess
Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide. Heteromer
Q15750;
5-353
SB4;
Assess
Crystal structure of phosphorylated p38aMAPK in complex with TAB1 Heteromer
Q15750;
5-352
NI;AGS;MG;
Assess
Structure of p38alpha complex Heteromer
P49137;
6-353
Assess
Crystal structure of p38alpha in complex with a MAPK docking partner Heteromer
Q9Y6W6;
5-352
Assess
Ternary complex of P38 and MK2 with a P38 inhibitor Heteromer
P49137;
6-353
39G;
Assess
Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, …homo-2-mer4-353
87B;ATP;
Assess
Crystal structure of p38 in complex with SR72monomer1-360
EDO;O8Q;
Assess
A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing …monomer5-360
BOG;WHQ;
Assess
Fragment KCL802 in complex with MAP kinase p38-alphamonomer5-359
SB4;CA;DMS;LOT;
Assess
Fragment KCL_916 in complex with MAP kinase p38-alphamonomer5-359
OFZ;SB4;CA;CL;SO4;
Assess
Fragment KCL_914 in complex with MAP kinase p38-alphamonomer5-359
OG2;SB4;CA;CL;SO4;
Assess
Fragment KCL_804 in complex with MAP kinase p38-alphamonomer6-360
SB4;CA;308;
Assess
Fragment KCL_771 in complex with MAP kinase p38-alphamonomer5-359
SB4;CA;CL;OFQ;
Assess
Fragment KCL_1410 in complex with MAP kinase p38-alphamonomer5-359
OG8;SB4;CA;CL;SO4;
Assess
Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;LOT;LOW;SO4;
Assess
Fragment KCL_K767 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;OL8;
Assess
Fragment KCL_K777 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;OKZ;
Assess
Novel p38-alpha crystal lattice with highly exposed p38/TAB1 non-canonical PPI surface.monomer6-359
SB4;CA;CL;
Assess
Fragment KCL615 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;CL;LOW;
Assess
Fragment KCL_1337 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;CL;OFW;
Assess
Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;CL;OFQ;LOT;
Assess
Fragment KCL_1088 in complex with MAP kinase p38-alphamonomer6-359
SB4;CA;CL;DMS;EDO;OG5;
Assess
Crystal structure of phosphorylated p38alpha MAP kinasemonomer1-354
Assess
Crystal structure of p38 in complex with SR68monomer5-355
O8Z;EDO;
Assess
Crystal structure of p38 in complex with SR69monomer5-355
O8T;EDO;
Assess
Crystal structure of p38 in complex with SR65monomer5-355
O98;EDO;
Assess
Crystal structure of p38 in complex with SR43monomer5-355
OU2;EDO;
Assess
Crystal structure of p38 in complex with SR63.monomer5-355
O8W;EDO;
Assess
Crystal structure of p38 alpha MAPK14 in complex with VPC00628monomer4-353
6SH;
Assess
Mutated Mus Musculus P38 Kinase (mP38)monomer4-353
PGJ;
Assess
Dual binding mode of pyridinylimidazole to MAP kinase p38monomer5-354
SB2;
Assess
p38a bound with MCP-81monomer4-353
OE5;
Assess
Crystal structure of WT p38alphamonomer4-353
MG;SB2;
Assess
Crystal structure of p38alpha C162S in complex with SB20358 and CAS 2094667-81-7 (behind catalytic …monomer5-354
IIM;87B;
Assess
The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solutionmonomer4-353
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP …monomer4-352
SOV;CL;MG;SO4;DMS;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14274a in complex with MAP…monomer4-352
SRJ;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL077 in complex with MAP …monomer4-352
SOJ;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14246a in complex with MAP…monomer4-352
SR4;CL;SO4;DMS;MG;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP…monomer4-352
LXS;CL;MG;SO4;DMS;
Assess
Fragment N13788a in complex with MAP kinase p38-alphamonomer4-352
LOK;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL093 in complex with MAP …monomer4-352
SQ4;CL;MG;SO4;EDO;
Assess
Fragment N13460a in complex with MAP kinase p38-alphamonomer4-352
JGG;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP…monomer4-352
SNJ;CL;MG;SO4;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP …monomer4-352
SO7;CL;MG;SO4;DMS;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08078b in complex with MAP…monomer4-352
SMV;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP…monomer4-352
JFS;CL;MG;SO4;
Assess
Crystal structure of p38alpha in complex with SR154monomer4-352
OSZ;EDO;
Assess
Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR276monomer4-352
EDO;TKB;
Assess
p38a bound with SR92monomer5-353
OEB;EDO;
Assess
Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR159monomer4-352
TK5;
Assess
THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTIONmonomer5-353
Assess
Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1monomer5-353
Assess
Crystal structure of WT p38alphamonomer4-352
SB2;MG;
Assess
MAPK14 bound with SR302monomer5-353
TBK;
Assess
MAPK14 bound with SR300monomer5-353
TJZ;EDO;MES;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13662a in complex with MAP…monomer5-352
RUY;CL;SO4;MG;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13596a in complex with MAP…monomer5-352
SSY;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09139b in complex with MAP…monomer5-352
SLV;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05703b in complex with MAP…monomer5-352
SLS;CL;SO4;DMS;MG;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ658 in complex with MAP …monomer5-352
SQV;CL;MG;SO4;
Assess
Fragment N13565a in complex with MAP kinase p38-alphamonomer5-352
CL;SO4;LPZ;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment K00283c in complex with MAP…monomer5-352
JND;CL;MG;SO4;DMS;
Assess
Fragment RZ132 in complex with MAP kinase p38-alphamonomer5-352
LO8;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13838a in complex with MAP…monomer5-352
SQM;CL;MG;SO4;GOL;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11302a in complex with MAP…monomer5-352
SVJ;CL;MG;SO4;DMS;
Assess
Fragment N11290a in complex with MAP kinase p38-alphamonomer5-352
LOQ;CL;MG;SO4;EDO;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP…monomer5-352
SU7;CL;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09036b in complex with MAP…monomer5-352
SV4;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N10836b in complex with MAP…monomer5-352
SVD;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11337a in complex with MAP…monomer5-352
SVG;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N06122b in complex with MAP…monomer5-352
54F;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08141b in complex with MAP…monomer5-352
PO6;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP…monomer5-352
LVD;CL;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N01381c in complex with MAP…monomer5-352
SN4;CL;MG;SO4;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13866a in complex with MAP…monomer5-352
JGM;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13502a in complex with MAP…monomer5-352
AYS;CL;MG;SO4;DMS;
Assess
Fragment N13569a in complex with MAP kinase p38-alphamonomer5-352
LO5;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13475a in complex with MAP…monomer5-352
JMM;CL;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14109a in complex with MAP…monomer5-352
SQG;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08051b in complex with MAP…monomer5-352
SWD;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment S00888c in complex with MAP…monomer5-352
N9J;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13470a in complex with MAP…monomer5-352
A9B;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13611a in complex with MAP…monomer5-352
NZ4;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13430a in complex with MAP…monomer5-352
SFY;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment PC587 in complex with MAP k…monomer5-352
RGY;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11396a in complex with MAP…monomer5-352
SLY;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL057 in complex with MAP …monomer5-352
SNV;CL;MG;SO4;DMS;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14074a in complex with MAP…monomer5-352
7ZC;CL;MG;SO4;ACT;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13413a in complex with MAP…monomer5-352
K3D;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP …monomer5-352
SQ7;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13693a in complex with MAP…monomer5-352
S7S;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05711b in complex with MAP…monomer5-352
2O6;CL;MG;SO4;DMS;
Assess
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717monomer5-352
SO4;LIE;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP…monomer5-352
6T5;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13418a in complex with MAP…monomer5-352
A7K;CL;MG;SO4;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ795 in complex with MAP …monomer5-352
SQY;CL;SO4;DMS;EDO;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11338a in complex with MAP…monomer5-352
SVM;CL;SO4;DMS;
Assess
Fragment N14056a in complex with MAP kinase p38-alphamonomer5-352
LOE;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP…monomer5-352
STV;CL;MG;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP…monomer5-352
SU7;CL;MG;SO4;DMS;EDO;
Assess
p38 inhibitor-boundmonomer5-352
P7B;BOG;
Assess
Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579monomer5-352
LID;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP…monomer5-352
JFS;CL;SO4;DMS;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11351a in complex with MAP…monomer5-352
SW7;CL;MG;SO4;DMS;
Assess
Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone In…monomer5-352
LI9;
Assess
PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13724a in complex with MAP…monomer5-352
SQP;CL;MG;SO4;DMS;
Assess
P38 inhibitor-boundmonomer5-352
BOG;P5K;
Assess
Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743monomer5-352
LIB;
Assess
P38 inhibitor-boundmonomer5-352
BOG;P79;
Assess
P38 inhibitor-boundmonomer5-352
BOG;P78;
Assess
p38 inhibitor-boundmonomer5-352
BOG;P7C;
Assess
p38 inhibitor-boundmonomer5-352
BOG;P7A;
Assess
Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449monomer5-352
LIC;
Assess
Crystal structure of p38 complex with 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-morpholin-…monomer5-352
G2G;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6y4x.1.Amonomer0.831-360
O8Q;100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24loo.1.Amonomer0.845-254
SB4;100.00
Assess
Isoform 36y4x.1.Amonomer0.831-360
O8Q;96.11
Assess
Isoform 45ra2.1.Amonomer0.861-275
100.00
Assess